U.S. Covid test makers anticipate layoffs after government reallocates funds

Domestic Covid test manufacturers are wrestling with the federal government’s decision to shuttle an already dwindling amount of Covid-19 funding to vaccines and treatment and away from testing.

“Testing manufacturing capacity is already heading to 65% of pre-peak production, and we estimate that we could lose thousands of additional American jobs in the coming weeks,” an HHS spokesperson said in an email to STAT.